US Bancorp’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-9,358
| Closed | -$1.55M | – | 4258 |
|
|
2021
Q2 | $1.55M | Sell |
9,358
-343
| -4% | -$57.3K | ﹤0.01% | 991 |
|
|
2021
Q1 | $1.49M | Buy |
9,701
+992
| +11% | +$135K | ﹤0.01% | 966 |
|
|
2020
Q4 | $1.09M | Buy |
8,709
+1,436
| +20% | +$161K | ﹤0.01% | 1072 |
|
|
2020
Q3 | $737K | Sell |
7,273
-461
| -6% | -$47K | ﹤0.01% | 1127 |
|
|
2020
Q2 | $753K | Buy |
7,734
+1,460
| +23% | +$136K | ﹤0.01% | 1091 |
|
|
2020
Q1 | $521K | Buy |
6,274
+327
| +5% | +$31.9K | ﹤0.01% | 1176 |
|
|
2019
Q4 | $661K | Buy |
5,947
+2,728
| +85% | +$281K | ﹤0.01% | 1230 |
|
|
2019
Q3 | $319K | Buy |
3,219
+501
| +18% | +$49.8K | ﹤0.01% | 1578 |
|
|
2019
Q2 | $269K | Sell |
2,718
-949
| -26% | -$90.6K | ﹤0.01% | 1691 |
|
|
2019
Q1 | $404K | Buy |
3,667
+307
| +9% | +$32.1K | ﹤0.01% | 1484 |
|
|
2018
Q4 | $309K | Buy |
3,360
+960
| +40% | +$97.1K | ﹤0.01% | 1550 |
|
|
2018
Q3 | $265K | Buy |
2,400
+40
| +2% | +$4.17K | ﹤0.01% | 1725 |
|
|
2018
Q2 | $221K | Sell |
2,360
-1,345
| -36% | -$116K | ﹤0.01% | 1826 |
|
|
2018
Q1 | $307K | Sell |
3,705
-100
| -3% | -$8.88K | ﹤0.01% | 1656 |
|
|
2017
Q4 | $346K | Buy |
3,805
+1,756
| +86% | +$146K | ﹤0.01% | 1602 |
|
|
2017
Q3 | $156K | Buy |
2,049
+945
| +86% | +$71.4K | ﹤0.01% | 1994 |
|
|
2017
Q2 | $83K | Hold |
1,104
| – | – | ﹤0.01% | 2290 |
|
|
2017
Q1 | $72K | Buy |
+1,104
| New | +$65K | ﹤0.01% | 2304 |
|
|
2016
Q4 | – | Sell |
-1,870
| Closed | -$106K | – | 3682 |
|
|
2016
Q3 | $106K | Buy |
+1,870
| New | +$91.7K | ﹤0.01% | 2051 |
|
Other funds holding PRAH
US Bancorp's PRAH Position: Q3 2021 in Review
US Bancorp sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 9,358 shares — an estimated $1.55M sold.
US Bancorp first reported a position in PRAH in Q3 2016 and held it in 19 quarters. The position peaked at $1.55M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- US Bancorp reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- US Bancorp sold 9,358 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.55M.
- US Bancorp first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 19 quarters.
- US Bancorp's PRA Health Sciences, Inc. position peaked at $1.55M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on US Bancorp's 13F filing for Q3 2021, filed 10 Nov 2021.